TAZ-induced Cybb contributes to liver tumor formation in non-alcoholic steatohepatitis
Xiaobo Wang, Sharon M. Zeldin, Hongxue Shi, Changyu Zhu, Yoshinobu Saito, Kathleen E. Corey, Stephanie A. Osganian, Helen Remotti, Elizabeth C. Verna, Utpal B. Pajvani, Robert F. Schwabe, Ira Tabas
Topics & Concepts
Gene silencingSteatohepatitisBiologyCancer researchHepatocyteHepatocellular carcinomaFatty liverMolecular biologyGeneInternal medicineMedicineGeneticsDiseaseIn vitroHippo pathway signaling and YAP/TAZLiver Disease Diagnosis and TreatmentPI3K/AKT/mTOR signaling in cancer